Cargando…
Discovery and Optimization of a Synthetic Class of Nectin-4-Targeted CD137 Agonists for Immuno-oncology
[Image: see text] CD137 (4-1BB) is a co-stimulatory receptor on immune cells and Nectin-4 is a cell adhesion molecule that is overexpressed in multiple tumor types. Using a series of poly(ethylene glycol) (PEG)-based linkers, synthetic bicyclic peptides targeting CD137 were conjugated to Bicycles ta...
Autores principales: | Upadhyaya, Punit, Kristensson, Julia, Lahdenranta, Johanna, Repash, Elizabeth, Ma, Jun, Kublin, Jessica, Mudd, Gemma E., Luus, Lia, Jeffrey, Phil, Hurov, Kristen, McDonnell, Kevin, Keen, Nicholas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340768/ https://www.ncbi.nlm.nih.gov/pubmed/35819182 http://dx.doi.org/10.1021/acs.jmedchem.2c00505 |
Ejemplares similares
-
Anticancer immunity induced by a synthetic tumor-targeted CD137 agonist
por: Upadhyaya, Punit, et al.
Publicado: (2021) -
BT7480, a novel fully synthetic Bicycle tumor-targeted immune cell agonist™ (Bicycle TICA™) induces tumor localized CD137 agonism
por: Hurov, Kristen, et al.
Publicado: (2021) -
BT8009; A Nectin-4 Targeting Bicycle Toxin Conjugate for Treatment of Solid Tumors
por: Rigby, Michael, et al.
Publicado: (2022) -
Discovery of
BT8009: A Nectin-4 Targeting Bicycle
Toxin Conjugate for the Treatment of Cancer
por: Mudd, Gemma E., et al.
Publicado: (2022) -
Nectin-4-targeted immunoSPECT/CT imaging and photothermal therapy of triple-negative breast cancer
por: Shao, Fuqiang, et al.
Publicado: (2022)